Infection Control News

The bivalent COVID-19 booster vaccine from Pfizer-BioNTech elicited a stronger response against the BQ.1.1 sublineage than the companies’ original vaccine in people aged 55 years and older, according to new data from the companies.

The 35th annual Infectious Diseases in Children Symposium will be held Nov. 19 and 20 in New York.

Six cases of nosocomial malaria that occurred in French hospitals may be attributed to a failure to adhere to precaution measures, researchers wrote in Clinical Infectious Diseases.

The 2023 Medicare Physician Fee Schedule does not reflect the important role infectious disease physicians play in safeguarding public health and is a “serious setback” to the ID workforce, the Infectious Diseases Society of America said.

Married women are less likely to receive sexually transmitted disease counseling and HIV testing in the year before a pregnancy compared with unmarried women, according to research presented at IDWeek 2022.

Novavax’s original COVID-19 vaccine and omicron subvariant vaccine candidate were both successful in a phase 3 trial, according to the company.

Moderna said Monday that data from a phase 2/3 trial showed that its bivalent COVID-19 booster shot triggers a higher antibody response against SARS-CoV-2 omicron subvariants than its original vaccine.

Although clinical and cycle threshold value assessment can distinguish COVID-19 reinfection from detecting virus from a prior infection, it failed to identify 33% of genomically supported reinfections, according to a recent study.

Boston-area school districts that lifted mask mandates earlier this year experienced nearly 45 more cases of COVID-19 per 1,000 students and staff than school districts that kept their mandates in place, a study found.

Social determinants of health, including lower socioeconomic status and a higher proportion of racially minoritized groups, correlated with higher likelihood of COVID-19-related death, according to a recent study in Clinical Infectious Diseases.